首页> 外国专利> PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT OF RADIATION THERAPY

PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT OF RADIATION THERAPY

机译:外周血生物标记物,用于评估放射治疗的抗肿瘤免疫作用

摘要

Provided is a peripheral blood biomarker for evaluating the anti-tumor immune effect of radiation therapy. Also provided is a method in which the composition of cell subpopulation in a sample obtained from a subject is used as an index for immune activation in the subject caused by a radiation therapy. By comparing, with a reference, the amount of CD4+ T cell subpopulation that correlates with dendritic cell stimulation in an anti-tumor immune response or the amount of dendritic cell subpopulation that correlates with the dendritic cell stimulation in an anti-tumor immune response, the presence or absence of, and/or the magnitude of, immune activation occurring in the subject as a result of a radiation therapy can be determined.
机译:提供了用于评估放射疗法的抗肿瘤免疫作用的外周血生物标志物。还提供了一种方法,其中将从受试者获得的样品中的细胞亚群的组成用作由放射疗法引起的受试者中免疫活化的指标。通过比较与抗肿瘤免疫反应中与树突状细胞刺激相关的CD4 + T细胞亚群的量或与树突状细胞刺激中相关的树突细胞亚群的量可以确定由于放射疗法而在受试者中发生的抗肿瘤免疫应答,免疫激活的存在与否和/或强度。

著录项

  • 公开/公告号WO2020171138A1

    专利类型

  • 公开/公告日2020-08-27

    原文格式PDF

  • 申请/专利权人 SAITAMA MEDICAL UNIVERSITY;

    申请/专利号WO2020JP06616

  • 发明设计人 KAGAMU HIROSHI;

    申请日2020-02-19

  • 分类号A61K39/395;A61K45;A61P35;A61P43;C07K16/34;C12N5/0783;C12Q1/06;G01N33/48;G01N33/53;G01N33/574;

  • 国家 WO

  • 入库时间 2022-08-21 11:09:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号